Global RNA Based Therapeutics Market
Outlook on the RNA Based Therapeutic Global Market to 2030 - Multifactorial Disease Targeting Presents Opportunities
April 28, 2022 06:43 ET | Research and Markets
Dublin, April 28, 2022 (GLOBE NEWSWIRE) -- The "RNA Based Therapeutic Market by Disease Type, Application and End User: Global Opportunity Analysis and Industry Forecast, 2021-2030" report has been...
Global RNAi Therapeutics Market
Global RNAi Therapeutics Market Insights & Forecast Report 2022-2026: Rising Utilization in Oncology Pharmaceuticals & Progress in Collaborations and Associated Deals in RNAi Therapeutics
April 21, 2022 04:43 ET | Research and Markets
Dublin, April 21, 2022 (GLOBE NEWSWIRE) -- The "Global RNAi Therapeutics Market (by Molecule Type, Application, End-User & Region): Insights & Forecast with Potential Impact of COVID-19...
22157.jpg
Global RNAi Therapeutics Market Report 2022-2026: Analysis by Molecule Type - Small Interference RNA (siRNA), and Micro RNA (miRNA)
April 08, 2022 06:23 ET | Research and Markets
Dublin, April 08, 2022 (GLOBE NEWSWIRE) -- The "Global RNAi Therapeutics Market: Analysis By Molecule Type, By Application, By Region Size and Trends with Impact of COVID-19 and Forecast up to 2026"...
Picture1.jpg
Oncotelic Presenting at MedInvest Pharmaceutical and Biotechnology Investor Conference
February 24, 2022 08:47 ET | Oncotelic Therapeutics, Inc.
OT-101 is Oncotelic’s RNA Therapeutic Against TGF-βOT-101 has completed over six clinical trials against solid tumors with good efficacyOT-101 is currently undergoing a phase 1b trial in combination...
22157.jpg
mRNA Therapeutics and Vaccine Market Report 2022: Key Opinion Leaders Profiles and Recent Activity Snapshots
February 24, 2022 04:28 ET | Research and Markets
Dublin, Feb. 24, 2022 (GLOBE NEWSWIRE) -- The "mRNA Therapeutics and Vaccines: Key Opinion Leaders" report has been added to ResearchAndMarkets.com's offering. Over the last two decades, medical...
22157.jpg
Global RNA Stabilization & Delivery Technology Advances Market Report 2021: LNP- and Bioconjugation-based Nonviral RNA Delivery Technologies to Gain Momentum in the Next 3 Years
February 15, 2022 05:43 ET | Research and Markets
Dublin, Feb. 15, 2022 (GLOBE NEWSWIRE) -- The "Technological Advances in RNA Stabilization & Delivery" report has been added to ResearchAndMarkets.com's offering. RNA therapeutics is a rapidly...
Global Nucleic Acid Based Gene Therapy Market
Global Nucleic Acid Based Gene Therapy Market Research Report 2021 Featuring Wave Life Sciences, Imugene, Caperna, Phylogica, Benitec, EGEN, BioMedica, Transgene and Copernicus Therapeutics
February 07, 2022 04:08 ET | Research and Markets
Dublin, Feb. 07, 2022 (GLOBE NEWSWIRE) -- The "Nucleic Acid Based Gene Therapy Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com's...
22157.jpg
Global microRNA Markets Report 2021-2028 - High Investments in miRNA R&D Initiatives for Development of New Diagnostic Tests & Therapeutics
September 15, 2021 07:13 ET | Research and Markets
Dublin, Sept. 15, 2021 (GLOBE NEWSWIRE) -- The "Global microRNA Market Size, Share & Trends Analysis Report 2021-2028" report has been added to ResearchAndMarkets.com's offering. The global...
22157.jpg
2021 Insights on the RNA Therapeutics Global Market - Stability of mRNA Vaccines and RNA Therapeutics at Ambient Temperature Presents Opportunities
July 15, 2021 05:23 ET | Research and Markets
Dublin, July 15, 2021 (GLOBE NEWSWIRE) -- The "RNA Therapeutics: Global Technology Growth Opportunities, 2021" report has been added to ResearchAndMarkets.com's offering. RNA therapeutics is a...
22157.jpg
Global Antisense & RNAi Therapeutics Market Report 2021: Market is Expected to Reach $1.79 Billion in 2025 at a CAGR of 11% - Forecast to 2030
June 17, 2021 07:03 ET | Research and Markets
Dublin, June 17, 2021 (GLOBE NEWSWIRE) -- The "Antisense & RNAi Therapeutics Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com's...